Smith & Nephew PLC (SN) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally.

Total Revenue Chart for Smith & Nephew PLC

Smith & Nephew PLC (SN) revenue for FY2025 was GBP 6.2B, a 6.1% change from FY2024. Smith & Nephew PLC's revenue grew from GBP 609.4M in 1985 to GBP 6.2B in 2025 (911.5% over 40 years). Earnings per share grew from GBP 0.23 in 2000 to GBP 0.25 in 2022 (8.7%). Revenue compound annual growth rate: 5-year CAGR of 6.2%, 10-year CAGR of 2.9%, 20-year CAGR of 4.5%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (British Pounds)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
£9.31B
Implied Share Price
£11.13
Enterprise Value
£11.54B
Revenue (TTM)
£6.30B
EBITDA
£1.38B
Profit Margin
10.08%
Trailing P/E
20.23
Forward P/E
12.02
Price/Book (MRQ)
2.39
Price/Sales (TTM)
1.48
EV/EBITDA
9.81
EV/Revenue
2.45
Dividend Yield
3.59%
Book Value
£4.54
Free Cash Flow (FY2025)
£869.88M
Free Cash Flow Yield
9.34%

Snapshot as of 3rd November 2026 — not point-in-time controlled, may lag the live market by a few days.